Two out of five GI fellows are women, but women comprise less than 18 percent of practicing gastroenterologists and the number of women in leadership positions is even lower. Join the DHPA Diversity, Equity, and Inclusion Committee for a conversation with Dr. Aja McCutchen and Dr. Michelle Clermont of Atlanta Gastroenterology Associates, and Dr. Tonya […]
Continue Reading >>
Diversity Equity and Inclusion
As leaders and healers within our communities, we know that we have an important role to play in addressing factors that impact the health and well-being not only of our own patients but our communities as a whole – factors that include racism, bigotry, discrimination and related disparities in education, economic security and health care.
Reducing the Burden of Colorectal Cancer: AGA Position Statements
The AGA created an Executive Committee on the Screening Continuum to develop AGA Position Statements, which highlight the continuum of CRC screening, identify barriers, and work with stakeholders to eliminate existing barriers. These principles anticipate new, evolving screening strategies, which are still in development. Each statement is evidence-based. Read More >>
Continue Reading >>
Independent Healthcare Grants and Charitable Donations (Abbvie)
The Independent Healthcare Grants and Charitable Donations seek to help further education around current, new and emerging sciences and standards of care, as we know they are key to the patient experience.
Continue Reading >>
Community Grant Program (Walmart Foundation)
The Walmart Community Grant Program provides grants to support the unique needs of local communities in the service areas of Walmart and Sam’s Club stores.
Continue Reading >>
Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer (AGA)
Cancer clinical trials contribute critical information about the safety and efficacy of novel therapies but also provide patients access to cutting-edge treatments. Although trial enrollment has increased over the past 2 decades in the United States, notable differences remain between the sociodemographic profiles of patients affected by cancer and those participating in trials. Specifically, racial […]
Continue Reading >>
- 1
- 2
- 3
- …
- 5
- Next Page »